Pharmafile Logo

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

- PMLiVE

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research sites across 25 countries. For this particular study, the sponsor had never run an oncology study before, so we were commissioned to provide in-country support to help sites overcome patient recruitment challenges.

Download the case study here

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...

Diversity in Clinical Trials: A more inclusive approach in patient recruitment

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...

Innovative Trials partners with MS Society

UK-based patient recruitment company announces its annual charity partnership in support of multiple sclerosis

FREE Live Webinar – Accelerating Patient recruitment in Clinical Trials post COVID-19 – 8th June 2022

Innovative Trials and Parexel invite you to attend the live webinar

Innovative Trials named a finalist in the Inspiring Hertfordshire Awards

The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards

Innovative Trials suspends services in Russia in response to Ukraine war

Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.

Improving diversity in clinical trial patient recruitment

A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment...

Increasing patient randomisation rate by 200% for a Top 5 global pharma

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

FREE Live Webinar – Diversity in Clinical Trials – 24th February

Innovative Trials, Pfizer and Parexel invite you to attend the live webinar